Latest Content

FDA Approves Epkinly for Relapsed, Refractory Follicular Lymphoma

June 27th 2024, 12:09am

By Ashley Chan

The Food and Drug Administration approved Epkinly, a bispecific T-cell engager, for certain patients with follicular lymphoma.

Imfinzi Shows Promising Results in Muscle-Invasive Bladder Cancer

June 26th 2024, 9:00pm

By Alex Biese

Article

Patients saw improved event-free survival and overall survival with presurgical Imfinzi and chemotherapy followed by surgery and postsurgical Imfinzi.

Having a Cancer Community on Social Media Can Be Healing

June 26th 2024, 7:01pm

By Ashley Chan

Video

Talking about the good, bad and ugly aspects of cancer on social media is “the most healing part of this community,” a survivor said.

Surviving Acute Myeloid Leukemia Has Finally Sunk In

June 26th 2024, 5:00pm

By Mary Sansone

Article

Being able to live independently and enjoy life’s beauty summon feelings of gratitude and euphoria more often now.

Side Effects to Monitor During HER2-Positive Breast Cancer Treatment

June 26th 2024, 3:00pm

By Alex Biese

Article

One expert explained the common side effects at every line of treatment for metastatic HER2-positive breast cancer during the CURE® Educated Patient® Metastatic Breast Cancer Summit.

A Path After Cancer Doesn't Have to Be Linear

June 26th 2024, 1:00pm

By Jaymie Knox

Article

I used to think that having lung cancer canceled all of my life's plans, but I realized I shouldn't give it that much power.

MRD Status Associated With Event-Free Survival in T-Lymphoblastic Lymphoma

June 25th 2024, 9:00pm

By Ashley Chan

Article

In children with T-lymphoblastic lymphoma, having an MRD status of less than 0.1% may lead to more time without their cancer worsening or coming back.

Imdelltra for Small Cell Lung Cancer Addresses Key Unmet Needs

June 25th 2024, 7:00pm

By Ashley Chan

Article

Imdelltra has offered a new treatment option for patients with small cell lung cancer that “is not like anything we’ve ever seen before,” an expert said.

My New Image After Testicular Cancer

June 25th 2024, 5:00pm

By Brian Sluga

Article

After testicular cancer hindered my self-image and identity, I decided to create a five-point system to help me achieve a successful future.

Retevmo Approval the Beginning of Targeted Therapy for RET-Mutant Childhood Cancer

June 25th 2024, 3:00pm

By Brielle Benyon

Article

An expert discusses the recent approval for Retevmo for RET-positive pediatric thyroid cancer and ongoing research for this patient population.

My Community of Support During Multiple Cancers

June 25th 2024, 1:00pm

By Mary Donohue

Article

My oncologist said that having a supportive community during cancer is just as important as treatment and I could not agree more — it makes me thankful.

Dato-DXd Falls Short in Overall NSCLC Population, Shows Benefit in Non-Squamous Disease

June 24th 2024, 9:00pm

By Brielle Benyon

Article

Dato-DXd did not improve survival in the overall population with non-small cell lung cancer but did boost outcomes in patients with non-squamous disease.